scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1018803011 |
P356 | DOI | 10.1186/1471-244X-4-4 |
P932 | PMC publication ID | 387829 |
P698 | PubMed publication ID | 15102340 |
P50 | author | Peter Propping | Q1634165 |
Sven Cichon | Q28050103 | ||
Göran Sedvall | Q59358640 | ||
Rami Abou Jamra | Q62588766 | ||
Markus M Nöthen | Q37634364 | ||
Erik G Jönsson | Q43004484 | ||
Jonas Melke | Q44953329 | ||
P2093 | author name string | Johannes Schumacher | |
Lars Westberg | |||
Elias Eriksson | |||
Jessica Bah | |||
Roland Ivo | |||
P2860 | cites work | Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders | Q24308022 |
Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species | Q24311170 | ||
Molecular heterosis: a review | Q26810050 | ||
Serotonin receptor 1c gene assigned to X chromosome in human (band q24) and mouse (bands D-F4) | Q28207939 | ||
D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects | Q48943255 | ||
DRD4 dopamine receptor genotype and CSF monoamine metabolites in Finnish alcoholics and controls. | Q52015494 | ||
Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). | Q52034600 | ||
Relationships in Healthy Volunteers Between Concentrations of Monoamine Metabolites in Cerebrospinal Fluid and Family History of Psychiatric Morbidity | Q52104878 | ||
The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS | Q57419003 | ||
A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers | Q57844170 | ||
Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers | Q57844256 | ||
Dopamine D2-receptor gene polymorphisms in scandinavian chronic alcoholics | Q57844316 | ||
Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices | Q68184493 | ||
Serotonin-facilitated dopamine release in vivo: pharmacological characterization | Q70661667 | ||
Biochemical genetics of catecholamines in humans | Q71713540 | ||
Distribution of dopamine-β-hydroxylase in subcellular fractions of adrenal medulla | Q72239385 | ||
Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis | Q72632948 | ||
Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C) | Q28289214 | ||
A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus | Q28347490 | ||
Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response | Q28361164 | ||
Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine | Q28509847 | ||
Dopamine-related genes and their relationships to monoamine metabolites in CSF. | Q33486319 | ||
Identification of a polymorphism in the promoter region of DRD4 associated with the human novelty seeking personality trait | Q33889983 | ||
The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity | Q33904818 | ||
Association between Novelty Seeking and the -521 C/T polymorphism in the promoter region of the DRD4 gene | Q33937524 | ||
Brain noradrenaline and the mechanisms of action of antidepressant drugs. | Q33972252 | ||
Brain dopamine D(4) receptors: basic and clinical status | Q34204549 | ||
Association between the 5' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder | Q34517004 | ||
Genetic polymorphisms and personality in healthy adults: a systematic review and meta-analysis | Q35155207 | ||
Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. | Q36437189 | ||
Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene (DRD4) with schizophrenia and personality traits | Q43566698 | ||
No association between a promoter dopamine D(4) receptor gene variant and schizophrenia. | Q43701982 | ||
No association of the -521 C/T polymorphism in the promoter of DRD4 with novelty seeking | Q43775300 | ||
Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study | Q44042486 | ||
No association between dopamine D4 receptor gene exon III and -521C/T polymorphism and novelty seeking. | Q44078809 | ||
DRD4 promoter SNPs and gender effects on Extraversion in African Americans | Q44112153 | ||
DRD4 and novelty seeking: results of meta-analyses | Q44124683 | ||
A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function | Q44253186 | ||
Lack of association between polymorphisms of the dopamine D4 receptor gene and personality | Q44329325 | ||
Allelic variants interaction of dopamine receptor D4 polymorphism correlate with personality traits in young Korean female population | Q44356009 | ||
Serotonin-related gene polymorphisms and central nervous system serotonin function | Q44357536 | ||
Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses | Q44369831 | ||
No association between a putative functional promoter variant in the dopamine beta-hydroxylase gene and schizophrenia | Q44576783 | ||
A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women | Q44616207 | ||
HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses | Q48108183 | ||
Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors | Q48149092 | ||
Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat. | Q48168840 | ||
Immunocytochemical localization of dopamine-beta-hydroxylase in neurons of the human brain stem | Q48175831 | ||
A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia | Q48209775 | ||
A 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons | Q48298237 | ||
Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method | Q48375217 | ||
No association between dopamine D4 receptor gene variants and novelty seeking | Q48651148 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 4 | |
P577 | publication date | 2004-03-04 | |
P1433 | published in | BMC Psychiatry | Q15750257 |
P1476 | title | Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers | |
P478 | volume | 4 |
Q33978386 | 3B but which 3B and that's just one of the questions: the heterogeneity of human 5-HT3 receptors. |
Q24644827 | A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB |
Q36004779 | A quantitative trait locus for variation in dopamine metabolism mapped in a primate model using reference sequences from related species |
Q46378952 | Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers |
Q36297843 | D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians |
Q36781213 | DBH gene as predictor of response in a cocaine vaccine clinical trial |
Q46703893 | Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice |
Q36259632 | Genetic association study and meta-analysis of the HTR2C Cys23Ser polymorphism and migraine |
Q34322551 | Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. |
Q36446037 | Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase |
Q34982551 | Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine |
Q44977105 | Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African-Caribbean inpatients: differences in association with dopamine and serotonin receptors |
Q34009349 | Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis |
Q36190118 | Polymorphisms of the serotonin transporter and receptor genes: susceptibility to substance abuse |
Q57395726 | Transmission disequilibrium analysis of the functional 5-HT3A receptor variant C178T in early-onset obsessive—compulsive disorder |
Q50540727 | Variability of plasma homovanillic acid over 13 months in patients with schizophrenia; relationship with the clinical response and the Wisconsin card sort test. |